CoChat

Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives

Open access
Somm, Emmanuel, Jornayvaz, François R · 2018 · Endocrine Reviews
Cited by 116

The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.

Abstract

Discovered 20 years ago, Fibroblast Growth Factor (FGF) 19, and its mouse ortholog FGF15, were the first members of a new subfamily of FGFs able to act as hormones.During fetal life, FGF15/19 is involved in organogenesis, affecting the development of the ear, eye, heart and brain.At adulthood, FGF15/19 is mainly produced by the ileum, acting on the liver to repress hepatic bile acid synthesis and promote postprandial nutrient partitioning.In rodents, pharmacologic doses of FGF19 induce the same anti-obesity and anti-diabetic actions as FGF21, these metabolic effects being partly mediated by the brain.However, activation of hepatocyte proliferation by FGF19 has long been a challenge to its therapeutic use.Recently, genetic reengineering of the molecule has resolved this issue.Despite a global overlap in expression pattern and function, murine FGF15 and human FGF19 exhibit several differences in terms of regulation, molecular structure, signaling and biological properties.As most of the knowledge originates from the use of FGF19 in murine models, differences between mice and humans in the biology of FGF15/19 have to be considered for a successful translation from bench to bedside.This review summarizes the basic knowledge concerning FGF15/19 in mice and humans, with a special focus on regulation of production, morphogenic properties, hepatocyte growth, bile acid homeostasis, as well as actions on glucose, lipid and energy homeostasis.Moreover, implications and therapeutic perspectives concerning FGF19 in human diseases (including obesity, type 2 diabetes, hepatic steatosis, biliary disorders and cancer) are also discussed. ESSENTIAL POINTS• Human Fibroblast Growth Factor (FGF)19 and its mouse ortholog FGF15 are gut-derived circulating hormones (enterokines) which repress hepatic bile acid synthesis and change their composition, through the FGF receptor 4 and the co-receptor β-Klotho (KLB) complex.• FGF15/19 is involved in the early development of ear, eye, heart and brain during organogenesis, as well as in muscle growth at adulthood.• Mouse FGF15 and human FGF19 exhibit differences in terms of regulation, molecular structure, signaling and biological actions, implying a careful interpretation of data originating from the use of FGF19 in murine models.• In rodents, pharmacologic doses of FGF19 induce similar anti-obesity and anti-diabetic effects as FGF21.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1210/er.2018-00134

Cites

57 of 57 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 57 references

Cited by

See all 116

Metadata

Authors
Somm, E., & Jornayvaz, F. R.
Venue
Endocrine Reviews
Published
2018-08-14
Volume
39
Issue
6
Pages
960-989
ISSN
  • 0163-769X (ISSN-L)
  • 1945-7189
OpenAlex
W2885505553
Cited by
116
References
57
FWCI
3.22
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives. https://app.cochat.ai/papers/10.1210/er.2018-00134
The paper
Somm, E., & Jornayvaz, F. R. (2018). Fibroblast Growth Factor 15/19: From Basic Functions to Therapeutic Perspectives. Endocrine Reviews. https://doi.org/10.1210/er.2018-00134

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.